Blog - Consult Dr. Anderson
NHANES 2015 Updates from the “Fourth Report”
Regarding: Executive Summary to EDC-2: The Endocrine Society’s Second Scientific Statement on Endocrine-Disrupting Chemicals. Summary of the publication: In this new review paper prepared for the Endocrine Society on Endocrine Disrupting Chemicals (EDC) the authors review the available data on this growing health problem. The review focused on seven areas which included obesity and diabetes, …
Endocrine Disrupting Chemicals Read More »
Glutamine and Kidney Function – Effect on Nitrogen Balance
Introduction: Regarding l-glutamine and low kidney function I’ll attempt to give the organic functional explanation for the use of l-glutamine in kidney treatment first, and then address the issues presenting in these patients second. l-glutamine is key in the function of the GI tract and the kidney, as well as numerous applications in the brain, …
Glutamine and Kidney Function – Effect on Nitrogen Balance Read More »
Vitamin C in COVID-19 (SARS-CoV-2) – Updates
Vitamin C in COVID-19 (SARS-CoV-2) – Updates The use of Vitamin C (Ascorbic Acid) in the prevention and treatment of COVID-19 (aka SARS-CoV-2) has received much attention in the popular media and in scientific journals for the past year. This review will look at two critical updates from the science: 1. What do we know …
Vitamin C in COVID-19 (SARS-CoV-2) – Updates Read More »
Acquired Hemolysis Related to Common IV Nutrient Therapies
Clinical Practice Guidelines Acquired Hemolysis Related to Common IV Nutrient Therapies – Clinical Practice GuidelinesBackground: Acquired hemolytic crisis is a known entity in clinical and emergency medicine. The causes of this phenomenon however are quite varied and include many etiologies not common to the general practice of IV nutrient therapy (IVNT). There are however two instances particular …
Acquired Hemolysis Related to Common IV Nutrient Therapies Read More »
Nutrient Injection Therapies for Chronic Fatigue and Fibromyalgia
Introduction: The purpose of this review is to collate and summarize some of the available scientific data regarding potential causes, aggravations and therapies in the Fibromyalgia / Chronic Fatigue (FMS/CFS) and like syndromes. This review is not intended to be encyclopedic in its scope but rather to give some data driven rationale for common therapies …
Nutrient Injection Therapies for Chronic Fatigue and Fibromyalgia Read More »
Anderson Biofilm Phase 2 BT Handout
Free PDF download from Dr. Anderson: Click here to download!
“COVID Therapeutics” – What does that mean?
“COVID Therapeutics” – What does that mean? Biological Drugs, Antibodies, Old Drugs, Vaccines and More… Dr. Paul S. Anderson INTRODUCTION: Why am I hearing “We’ll soon have COVID Therapeutics” on the News? It sounds like this is our road back to something near normal… Is it? The term “COVID Therapeutics” as used in most media …
“COVID Therapeutics” – What does that mean? Read More »
Ascorbic Acid (Vitamin C) is seemingly so ubiquitous an intervention in integrative healthcare it is easy to overlook its potential therapeutic benefit as well as economical cost profile when considering therapies. One therapeutic target that is both common and often filled with costly interventions is cardiovascular prevention and disease. This 2016 paper and the others …
Vitamin C and the Heart Read More »
Vitamin C for the Treatment of Coronavirus – Research Update
Presenter: Paul S. Anderson, NMD – Advanced Medical Therapies, Seattle Washington – ConsultDrAnderson.com Abstract: This presentation focuses on the role of ascorbate (vitamin C) in the treatment of COVID-19 and and its potentially fatal sequela. Pharmacokinetics, safety, and the current scientific literature are reviewed. Clinical applications of oral and intravenous vitamin C are discussed in …
Vitamin C for the Treatment of Coronavirus – Research Update Read More »
ISOM Publication “Intravenous Ascorbic Acid for Supportive Treatment in Hospitalized Patients” PS Anderson, JOM, 2020
Originally posted in: https://isom.ca/article/intravenous-ascorbic-acid-for-supportive-treatment-in-hospitalized-covid-19-patients/ Author(s): Paul S. AndersonDate of Publication: 24 MARCH 2020Citation: Anderson PS (2020) Intravenous ascorbic acid for supportive treatment in hospitalized COVID-19 patients. J Orthomol Med. 35(1) Abstract Intravenous ascorbic acid (IVAA) is a well-known intervention in medicine, which currently is rarely used in US hospitals. Due to the unusual and extreme …
ISOM Publication “Intravenous Ascorbic Acid for Supportive Treatment in Hospitalized Patients” PS Anderson, JOM, 2020 Read More »
Genetic variation, something beyond classic comorbidity? “COVID-19” illness caused by the SARS CoV-2 virus has such a variety of symptoms when they contract it. It is said that “comorbidity” (other prior health conditions) are the reason some have mild illness and some severe illness. This is likely true, but we also see people with no …
COVID-19 and Genomics Read More »
Nutrients and COVID-19
A Review of Recent Research Dr. Paul Anderson 08-05-2020 I always find the “official” response to health crises interesting and even comical at times. COVID-19 (the acronym I will use here to indicate the disease caused by SARS-CoV-2 infection) has been the usual batch of interesting information and so much more. Even today (but especially …
Nutrients and COVID-19 Read More »
Heavy Metals, Bone Turnover, Osteopenia and Osteoporosis Assessment and Treatment
You will see data showing LOWER levels of metals (blood or urine) associated with LOWER levels of osteopenia and or osteoporosis. This is because the people with MORE bone turnover have MORE dumping of metals from bone. An important issue is if you JUST chelate you will have HIGH metals on the testing probably as …
Heavy Metals, Bone Turnover, Osteopenia and Osteoporosis Assessment and Treatment Read More »
Mycoplasma and Chlamydia Clinical Notes
BACKGROUND: “Mycoplasma” refers to any organism within the class Mollicutes, composed of five genera (Mycoplasma, Ureaplasma, Acholeplasma, Anaeroplasma, and Asteroloplasma). Over 120 named “Mycoplasma” species exist with13 Mycoplasma species, two Acholeplasma species, and one Ureaplasma species have been isolated from humans. However, only three species are well-established human pathogens (but others likely exist): Mycoplasma pneumoniae, …
Mycoplasma and Chlamydia Clinical Notes Read More »
A great deal of information circulates about ascorbic acid and various forms of it which are available. Thoughts as to its chemistry, absorption, and bioavailability and other factors are debated more so in the arena of social media and less so in the scientific community. In this blog, I will address the difference between ascorbic …
Ascorbic Acid versus Sodium Ascorbate Read More »
In the primary document (IVAA-COVID-19) is a summary any hospital can use to base IV Vitamin C therapy for COVID-19 using the most common Chinese IVC data with COVID patients. The other two (Shanghai-Consensus) are the English translation and original Chinese research.
6C – Chelation, Detoxification, Magnesium, other Mineral levels and Platinum Based Chemotherapies
[gdlr_button href=”https://www.consultdranderson.com/wp-content/uploads/securepdfs/2019/10/6C-Detox-Chelation-Minerals-Platinum-Chemotherapy.pdf” target=”_blank” size=”large” background=”#ed4b2f” color=”#ffffff”]Download PDF[/gdlr_button] Question: I have been told that we should wait two or more years after platinum based chemotherapy to begin any detoxification. But I have now heard conflicting information – has something changed? Answer: That was a common and long held belief that for maximum efficacy one should not …
6C – Chelation, Detoxification, Magnesium, other Mineral levels and Platinum Based Chemotherapies Read More »
6B – Leukemia and Oxidative Therapies Including Intravenous Ascorbic Acid / HDIVC
[gdlr_button href=”https://www.consultdranderson.com/wp-content/uploads/securepdfs/2019/10/6B-2019-IVC-Ascorbate-Leukemia-Update.pdf” target=”_blank” size=”large” background=”#ed4b2f” color=”#ffffff”]Download PDF[/gdlr_button] A seeming conundrum regarding the ability of some leukemic cells (i.e. CLL) to sequester ascorbate (ASC) has led to confusion regarding the safety and utility of high dose ascorbate delivered via IV (HDIVC). This has led to some apparent confusion between this concern and the apparent positive benefits …
6B – Leukemia and Oxidative Therapies Including Intravenous Ascorbic Acid / HDIVC Read More »
6A – 2019 IVC, Antioxidant – Chemo and Radiation Update
[gdlr_button href=”https://www.consultdranderson.com/wp-content/uploads/securepdfs/2019/10/6A-2019-IVC-Antioxidants-Chemo-and-Radiation-Update.pdf” target=”_blank” size=”large” background=”#ed4b2f” color=”#ffffff”]Download PDF[/gdlr_button] For whatever reasons this gem of an old paper is making a resurgence at many oncologists offices and being used as a justification to not start IVC, HDIVC etc. In short (abridged below) it says: Heaney ML, Gardner JR, Karasavvas N, Golde DW, Scheinberg DA, Smith EA, O’Connor …
6A – 2019 IVC, Antioxidant – Chemo and Radiation Update Read More »
Adding Heparin to IV’s to Avoid Thrombosis
Question: I am confused as some of your old notes and other clinicians recommend adding heparin to IV’s to avoid thrombosis. Is this correct? Answer: Good point. In my notes (and those of Dr. Osborne and I in the EDTA class) those are “historical purposes only” formulas as we say when presenting them. Reason is …
Adding Heparin to IV’s to Avoid Thrombosis Read More »
H.R. 1959 Preserving Patient Access to Compounded Medications Act of 2019
[gdlr_button href=”https://www.consultdranderson.com/wp-content/uploads/securepdfs/2019/06/HR1959.pdf” target=”_blank” size=”large” background=”#ed4b2f” color=”#ffffff”]Download PDF[/gdlr_button] 1. A Bill is being introduced in the US House of Representatives which will amend the language FDA must follow for compounding restrictions, legal and regulatory changes. This bill would open up the compounding substances (503<a>) process I have been involved in with the Integrative Medicine Coalition (IMC). …
H.R. 1959 Preserving Patient Access to Compounded Medications Act of 2019 Read More »
An interview about “Outside the Box Cancer Thinking”
Originally aired on March 28, 2019 on ctrnetwork.com In today’s program Dr. Anderson will be interviewed by Cameron Steele, co-owner of CTR Radio. Some topics in the interview include: If there is an “Outside the Box” with cancer thinking, what is “Inside the Box”? Why did you and Dr. Stengler write this book? How much …
An interview about “Outside the Box Cancer Thinking” Read More »